H. E. Frech

1.6k total citations
62 papers, 929 citations indexed

About

H. E. Frech is a scholar working on Economics and Econometrics, General Health Professions and Pharmacology. According to data from OpenAlex, H. E. Frech has authored 62 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Economics and Econometrics, 20 papers in General Health Professions and 6 papers in Pharmacology. Recurrent topics in H. E. Frech's work include Healthcare Policy and Management (25 papers), Global Health Care Issues (17 papers) and Pharmaceutical industry and healthcare (6 papers). H. E. Frech is often cited by papers focused on Healthcare Policy and Management (25 papers), Global Health Care Issues (17 papers) and Pharmaceutical industry and healthcare (6 papers). H. E. Frech collaborates with scholars based in United States, Switzerland and Australia. H. E. Frech's co-authors include Lee R. Mobley, Richard D. Miller, Paul Β. Ginsburg, Sandra Hopkins, William S. Comanor, George J. Borjas, Luc Anselin, Mark R. Greene, Kelly Bedard and Douglas M. Brown and has published in prestigious journals such as American Economic Review, The Quarterly Journal of Economics and Journal of Political Economy.

In The Last Decade

H. E. Frech

60 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. E. Frech United States 18 708 372 96 94 70 62 929
Rexford E. Santerre United States 18 747 1.1× 378 1.0× 82 0.9× 143 1.5× 89 1.3× 64 1.1k
W. Narendranathan United Kingdom 7 723 1.0× 189 0.5× 138 1.4× 91 1.0× 131 1.9× 8 997
Anindya Sen Canada 15 541 0.8× 164 0.4× 88 0.9× 189 2.0× 56 0.8× 70 902
R. Jason Faberman United States 12 763 1.1× 228 0.6× 118 1.2× 51 0.5× 71 1.0× 31 918
Harl E. Ryder United States 11 864 1.2× 220 0.6× 129 1.3× 94 1.0× 118 1.7× 15 1.1k
Rune J. Sørensen Norway 21 766 1.1× 410 1.1× 214 2.2× 71 0.8× 99 1.4× 108 1.5k
Omar Licandro Spain 19 1.2k 1.6× 315 0.8× 116 1.2× 135 1.4× 148 2.1× 58 1.4k
Jaap H. Abbring Netherlands 13 774 1.1× 368 1.0× 122 1.3× 69 0.7× 81 1.2× 49 1.2k
Hae-Shin Hwang United States 12 564 0.8× 102 0.3× 81 0.8× 40 0.4× 70 1.0× 36 732
Kurt Richard Brekke Norway 21 1.2k 1.7× 467 1.3× 70 0.7× 89 0.9× 72 1.0× 76 1.5k

Countries citing papers authored by H. E. Frech

Since Specialization
Citations

This map shows the geographic impact of H. E. Frech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. E. Frech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. E. Frech more than expected).

Fields of papers citing papers by H. E. Frech

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. E. Frech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. E. Frech. The network helps show where H. E. Frech may publish in the future.

Co-authorship network of co-authors of H. E. Frech

This figure shows the co-authorship network connecting the top 25 collaborators of H. E. Frech. A scholar is included among the top collaborators of H. E. Frech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. E. Frech. H. E. Frech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pauly, Mark V., et al.. (2021). Cost-Effectiveness Analysis of Branded Drugs With Market Demand and Insurance. Value in Health. 24(10). 1476–1483. 5 indexed citations
2.
Comanor, William S. & H. E. Frech. (2016). The Competitive Effects of Vertical Agreements. American Economic Review. 75(3). 539–546. 7 indexed citations
3.
Comanor, William S. & H. E. Frech. (2016). Strategic Behavior and Antitrust Analysis. American Economic Review. 74(2). 372–376.
4.
Frogner, Bianca K., H. E. Frech, & Stephen T. Parente. (2015). Comparing efficiency of health systems across industrialized countries: a panel analysis. BMC Health Services Research. 15(1). 415–415. 19 indexed citations
5.
Whaley, Christopher, H. E. Frech, & Richard M. Scheffler. (2015). Accountable Care Organizations in California: Market Forces at Work?. Journal of Health Politics Policy and Law. 40(4). 689–703. 11 indexed citations
6.
Mobley, Lee R., et al.. (2014). Macro-level factors impacting geographic disparities in cancer screening. Health Economics Review. 4(1). 13–13. 7 indexed citations
7.
Bedard, Kelly & H. E. Frech. (2009). Prison health care: is contracting out healthy?. Health Economics. 18(11). 1248–1260. 18 indexed citations
8.
Frech, H. E. & Kelly Bedard. (2007). Prison Health Care: Is Contracting Out Healthy?. SSRN Electronic Journal. 1 indexed citations
9.
Frech, H. E., et al.. (2006). An economic assessment of damage caps in medical malpractice litigation imposed by state laws and the implications for federal policy and law.. PubMed. 16(2). 693–722. 3 indexed citations
10.
Comanor, William S., H. E. Frech, & Richard D. Miller. (2006). Is the United States an outlier in health care and health outcomes? A preliminary analysis. International Journal of Health Care Finance and Economics. 6(1). 3–23. 18 indexed citations
11.
Frech, H. E. & Richard D. Miller. (2004). The Effects of Pharmaceutical Consumption and Obesity on the Quality of Life in the Organization of Economic Cooperation and Development (OECD) Countries. PharmacoEconomics. 22(Supplement 2). 25–36. 16 indexed citations
12.
Hopkins, Sandra & H. E. Frech. (2001). The Rise of Private Health Insurance in Australia: Early Effects on Insurance and Hospital Markets. The Economic and Labour Relations Review. 12(2). 225–238. 14 indexed citations
13.
Miller, Richard D. & H. E. Frech. (2000). Is There a Link Between Pharmaceutical Consumption and Improved Health in OECD Countries?*. PharmacoEconomics. 18(Supplement 1). 33–45. 41 indexed citations
14.
Frech, H. E., et al.. (1998). Exclusive contracts between hospitals and physicians: the antitrust issues. Health Economics. 7(2). 175–178. 6 indexed citations
15.
Frech, H. E. & Richard D. Miller. (1996). The Productivity of Health Care and Pharmaceuticals: An International Comparison. eScholarship (California Digital Library). 15 indexed citations
16.
Frech, H. E., et al.. (1992). Health Economics Worldwide. PubMed. 1. 1–365. 72 indexed citations
17.
Frech, H. E.. (1991). Contracting for property rights. Journal of Comparative Economics. 15(3). 536–538. 14 indexed citations
18.
Frech, H. E. & Paul Β. Ginsburg. (1988). Competition among Health Insurers, Revisited. Journal of Health Politics Policy and Law. 13(2). 279–291. 11 indexed citations
19.
Frech, H. E. & Paul Β. Ginsburg. (1978). Public insurance in private medical markets: Some problems of national health insurance. Medical Entomology and Zoology. 3 indexed citations
20.
Frech, H. E.. (1976). The Property Rights Theory of the Firm: Empirical Results from a Natural Experiment. Journal of Political Economy. 84(1). 143–152. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026